Definium Therapeutics issues options for 30,330 shares to new hires under inducement plan

• Definium Therapeutics issued inducement stock options covering 30,330 common shares to two newly hired non-executive employees.
• Options carry an effective grant date of July 20, 2026.
• Exercise price set at the closing price of Definium’s common shares on the grant date.
• Award vests over four years: 25% after year one, remainder in monthly installments over the next three years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607201601BIZWIRE_USPR_____20260720_BW055756) on July 20, 2026, and is solely responsible for the information contained therein.